Tracing the route taken by peptides and major histocompatibility complex class I molecules in presentation of exogenous antigens.
Norbury
C C
CC
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D017951:Antigen Presentation; D000938:Antigen-Presenting Cells / Q000166:cytology / Q000276:immunology*; D000941:Antigens / Q000378:metabolism*; D002738:Chloroquine / Q000494:pharmacology; D003572:Cytochalasins / Q000494:pharmacology; D004705:Endocytosis / Q000187:drug effects / Q000502:physiology; D016650:Fluorescein-5-isothiocyanate; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects / Q000502:physiology; D012680:Sensitivity and Specificity; D013050:Spectrometry, Fluorescence / Q000379:methods; D013601:T-Lymphocytes / Q000276:immunology; D001613:beta 2-Microglobulin / Q000378:metabolism
D000941:Antigens; D003572:Cytochalasins; D015395:Histocompatibility Antigens Class I; D001613:beta 2-Microglobulin; D000584:Amiloride; D002738:Chloroquine; D016650:Fluorescein-5-isothiocyanate